Is there any risk of immuonmodulation treatment for Crohn's disease in a woman with the brca1 gene?

Jury is out. There is no solid data on this to my knowledge. There are several potential immunomodulatory treatments ( which probably have their own independent risks ) and they are sometimes used in combination. Reports differ on risk but in general appears to be small and manageable. How this changes with brca1 ?